Vital cells maintain a steep potassium ion (K+) gradient
across the plasma membrane. Intracellular potassium ion concentrations
([K+]) and especially the [K+] within the
extracellular matrix are strictly regulated, the latter within a narrow range of
~3.5 to 5.0 mM. Alterations of the extracellular K+
homeostasis are associated with severe pathological alterations and systemic
diseases including hypo- or hypertension, heart rate alterations, heart failure,
neuronal damage or abnormal skeleton muscle function. In higher eukaryotic
organisms, the maintenance of the extracellular [K+] is mainly
achieved by the kidney, responsible for K+ excretion and
reabsorption. Thus, renal dysfunctions are typically associated with alterations
in serum- or plasma [K+]. Generally, [K+] quantifications
within bodily fluids are performed using ion selective electrodes. However,
tracking such alterations in experimental models such as mice features several
difficulties, mainly due to the small blood volume of these animals, hampering
the repetitive collection of sample volumes required for measurements using ion
selective electrodes. We have recently developed highly sensitive, genetically
encoded potassium ion indicators, the GEPIIs, applicable for in vitro
determinations of [K+]. In addition to the determination of
[K+] within bodily fluids, GEPIIs proved suitable for the
real-time visualization of cell viability over time and the exact determination
of the number of dead cells.